Orphazyme names the last day of trading in US

Crisis-struck Orphazyme has set a date for when trading with its American Depositary Shares (ADSs) ceases in the US: Wednesday, July 6.
by marketwire, translated by daniel pedersen

Danish biotech company Orphazyme, which is currently undergoing an in-court restructuring of its organization, reports that trading of its American Depositary Shares (ADSs) will terminate on July 6, a company press release has announced. Secondary trading of these assets ended last Friday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading